FDA Approved: PROLIA — Original Application (Amgen, Inc)

View source ↗

Summary

The FDA approved PROLIA (denosumab) in its original application by Amgen, establishing its use for osteoporosis in postmenopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Prolia (denosumab)

Snippet

ORIG AP for PROLIA (DENOSUMAB)